Methotrexate [clinicaltrials_resource:b98cff1c1220d3304b2ef1a531881afe]
condition [clinicaltrials_vocabulary:condition]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Autoimmunity in Inner Ear Disease [clinicaltrials:NCT00000361]clinicaltrials:NCT00000395Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members [clinicaltrials:NCT00000703]The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer [clinicaltrials:NCT00000723]A Phase I Study of Methotrexate for HIV Infection [clinicaltrials:NCT00000834]Steroids and Methotrexate to Treat Systemic Vasculitis [clinicaltrials:NCT00001256]A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer [clinicaltrials:NCT00001498]Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy [clinicaltrials:NCT00001677]Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]clinicaltrials:NCT00002463Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002547]clinicaltrials:NCT00002571clinicaltrials:NCT00002657clinicaltrials:NCT00002665clinicaltrials:NCT00002744clinicaltrials:NCT00002784Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]clinicaltrials:NCT00002812clinicaltrials:NCT00002816Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002961]506U78 in Treating Patients With Refractory Hematologic Cancer [clinicaltrials:NCT00002970]clinicaltrials:NCT00003019Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003056]clinicaltrials:NCT00003217Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma [clinicaltrials:NCT00003261]Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [clinicaltrials:NCT00003311]Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [clinicaltrials:NCT00003376]Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer [clinicaltrials:NCT00003536]S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer [clinicaltrials:NCT00003549]clinicaltrials:NCT00003553Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00003592]clinicaltrials:NCT00003593Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma [clinicaltrials:NCT00003632]clinicaltrials:NCT00003700Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003702]clinicaltrials:NCT00003910Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00003934]clinicaltrials:NCT00003937
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Methotrexate [clinicaltrials_resource:b98cff1c1220d3304b2ef1a531881afe]
Bio2RDF identifier
b98cff1c1220d3304b2ef1a531881afe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b98cff1c1220d3304b2ef1a531881afe
identifier
clinicaltrials_resource:b98cff1c1220d3304b2ef1a531881afe
title
Methotrexate
@en
type
label
Methotrexate [clinicaltrials_resource:b98cff1c1220d3304b2ef1a531881afe]
@en